TGen, the Translational Genomics Research Institute, is an affiliate of City of Hope. The institute is dedicated to conducting groundbreaking research with life-changing results and works to unravel the genetic components of common and complex diseases, including cancer, diabetes, neurological disorders, infectious disease, and rare childhood disorders. By identifying treatment options in this manner, TGen believes medicine becomes more rational, more precise, and more personal.

Advancement work at TGen is similarly personal, and the organization and related foundation are poised for significant fundraising success. Under the leadership of Chief Development Officer, Ms. Erin Massey, and in close partnership with City of Hope Chief Philanthropy Officer Ms. Kristin Bertell and the whole of the City of Hope Office of Philanthropy (OOP), the TGen Foundation is committed to supporting TGen’s and City of Hope’s missions to develop and deploy treatments as quickly as possible.